title: Randomised controlled trial: extended-duration dabigatran is non-inferior to warfarin and more effective than placebo for symptomatic VTE.
authors.affiliation: Divisions of Vascular Surgery, Hematology/Oncology, and Laboratory Medicine, Oregon Health & Science University, , Portland, Oregon, USA.
authors.forename: Timothy K
authors.initials: TK
authors.lastname: Liem
authors.forename: Thomas G
authors.initials: TG
authors.lastname: DeLoughery
mesh_terms: D001562:Benzimidazoles / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D054556:Venous Thromboembolism / Q000188:drug therapy*; D014859:Warfarin / Q000627:therapeutic use*; D015091:beta-Alanine / Q000031:analogs & derivatives*
chemical_list: D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin